Amneal Pharmaceuticals
AMRX19.0301.44% ( +0.270 )
Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and speci...
- Open
- 18.840
- High
- 19.140
- Low
- 18.800
- Prev. Close
- 18.760
- Volume
- 842.58K
- Turnover
- 15.99M
- Avg Price
- 18.974
- Bid/Ask Ratio
- --
- Amplitude
- 1.81%
- 52wk High
- 19.140
- Volume Ratio
- 0.61
- Turnover Ratio
- 0.47%
Amneal Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$18.75-1.37%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Stock Story · 15 hours ago
Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings
- Tip Ranks · 2 days ago, 06:37 AM
Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)
- MorningStar · Jul 23 at 12:44 PM
Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm
- ZeroHedge · Jul 22 at 08:45 AM
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
- rttnews · Jul 19 at 12:05 PM
5 Undervalued Stocks That Soared: SION +277%, FBRX +306%, NKTR +869% & More
- PUBT · Jul 17 at 07:02 AM
Amneal wins FDA approval for additional iohexol injection strengths and vial sizes
